Hemophagocytic Lymphohistiocytosis

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

Immune Disorder HSCT Protocol

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma

Administration of Donor T Cells With the Caspase-9 Suicide Gene

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

GTP Regimen in the Treatment of Refractory/Recurrent HLH

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH

Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)

DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH

Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH